Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.

Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms. Neuropathy is a common adverse effect of chemotherapy. The tricyclic antidepressant, amitriptyline, is a gold standard in the treatment of neuropathic pain. This double-blind, randomized placebo-controlled trial assessed the efficacy of amitriptyline to prevent chemotherapy-induced neuropathic symptoms. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Anticancer research Pubmed

Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.

Anticancer research , Volume 29 (7): -2594 – Sep 8, 2009

Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.


Abstract

Neuropathy is a common adverse effect of chemotherapy. The tricyclic antidepressant, amitriptyline, is a gold standard in the treatment of neuropathic pain. This double-blind, randomized placebo-controlled trial assessed the efficacy of amitriptyline to prevent chemotherapy-induced neuropathic symptoms.

Loading next page...
 
/lp/pubmed/amitriptyline-in-the-prevention-of-chemotherapy-induced-neuropathic-dzmfiwVPM0

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

eISSN
1791-7530
pmid
19596934

Abstract

Neuropathy is a common adverse effect of chemotherapy. The tricyclic antidepressant, amitriptyline, is a gold standard in the treatment of neuropathic pain. This double-blind, randomized placebo-controlled trial assessed the efficacy of amitriptyline to prevent chemotherapy-induced neuropathic symptoms.

Journal

Anticancer researchPubmed

Published: Sep 8, 2009

There are no references for this article.